Clinical trial Recruiting at 2 sites Phase 3 Interventional Ages 18 to 65

Using quetiapine to help veterans with post concussive syndrome after mild brain injuries

Official title: A Randomized Clinical Trial of Quetiapine to Reduce Post Concussive Syndrome Polypharmacy

Run by Foundation for Advancing Veterans' Health Research · NCT06333990 · Data updated 2026-11-12

This study tests if the medication quetiapine can help veterans aged 18-65 recover from post concussive syndrome after mild brain injuries better than standard treatments.

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment146 (estimated)
SponsorFoundation for Advancing Veterans' Health Research
Academic / other
Locations2 sites (Albuquerque, New Mexico and 1 other locations)
StatusRecruiting
StartedJuly 9, 2024
Main results expectedJune 2028
Study endsJune 2028
Registry record updatedJuly 11, 2025
Trial IDNCT06333990 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are male or female veterans aged 18-65 with a diagnosis of mild traumatic brain injury and post concussive syndrome symptoms.

Probably not a fit

Patients with moderate or severe traumatic brain injury or major psychiatric disorders such as schizophrenia or bipolar disorder may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase III clinical trial evaluates the effectiveness of quetiapine monotherapy compared to standard treatment for veterans experiencing post concussive syndrome following mild traumatic brain injury. The study involves two sites and focuses on veterans aged 18-65 who have been stable on multiple psychotropic medications. Participants will be assessed for their symptoms using established inventories to determine the impact of quetiapine on their recovery.

Why it matters

Potential benefit: If successful, this treatment could significantly alleviate symptoms of post concussive syndrome in veterans, improving their quality of life.

How similar studies have gone: Other studies have explored the use of quetiapine for various psychiatric conditions, but this specific application for post concussive syndrome in veterans is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Male or female veterans seeking treatment for mTBI, aged 18-65 years
2. Meet mTBI diagnosis and have PCS symptoms reported on the Neurobehavioral Symptom Inventory (NSI). Six months or more must elapse between the injury and Screening. mTBI diagnosis will be determined using the provisional diagnostic convention recommended by the VA/DoD requiring loss of consciousness, or a period of altered consciousness, or posttraumatic amnesia;
3. Be stable (i.e., no dose changes for \> 1 month) on at least three CNS active psychotropic medications prescribed for symptom relief or psychiatric treatment.
4. Have posttraumatic symptoms measured by PTSD Checklist for DSM-5 (PCL-5) score ≥25.

Exclusion Criteria:

1. Moderate or severe TBI, or major neurocognitive disorder (dementia).
2. Meet DSM-5 criteria for schizophrenia, bipolar disorder, schizoaffective disorder, or requiring inpatient hospitalization currently or within past 6 months.
3. Currently taking any antipsychotics or prohibited medication within the past month .
4. Known intolerance to quetiapine or a history of clinically unstable heart, lung, liver, renal, hematological, or endocrinological condition, diabetes mellitus, severe sleep apnea and/or seizure disorder.
5. Substance use disorder severe enough to require medication treatment or medical detoxification or inpatient hospitalization within 6 months of screening.
6. Reporting suicidal ideation of type 4 or 5 in the Columbia Suicide Severity Rating Scale (CSSRS) in the past 3 months prior to screening or at screening or baseline visit (i.e. active suicidal thought with method and intent but without specific plan, or active suicidal thought with method, intent, and plan); or homicidal ideation with intent or plan to harm others within 90 days or suicide attempt; or suicidal behavior within 6 months prior to screening.

   (Note: Study psychiatrist will be immediately notified when SI or HI intent is positive)
7. Current or known history of cardiac arrhythmia or QTc interval ≥ 470 milliseconds.
8. Pregnant or lactating women and those of child-bearing potential not using a reliable method of contraception will be excluded from participating in the study.

Where it's running

  • New Mexico VA Healthcare System
    Albuquerque, New Mexico, United States
    Recruiting
  • South Texas Veterans Healthcare System
    San Antonio, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.